Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Price:
17.63 USD
0.46%
Market Closed
Updated:
May 15, 2024
EV/OCF
Enterprise Value to OCF
Enterprise Value to OCF
20.8
Current
21.2
Median
15.4
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
EV/OCF
=20.8
Enterprise Value
/
6.1B
Operating Cash Flow
292.5m
All Countries
| Market Cap | EV/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
|
4.2B USD | 20.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 26.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 76.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 38 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 46.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 23.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 29.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
377.3B CNY | 28.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 56.9 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 61.7 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A
You don't have any saved screeners yet
